Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Breaking News

5/31/2018 » 6/3/2018
2018 OSAP Annual Conference

HIV Vaccine Research

HIV Vaccine Research



Nearly 37 million people are living with HIV around the world. In the United States, 1.2 million people are living with HIV, of whom 13 percent are unaware of their diagnosis. Although progress has been made in the global fight against HIV/AIDS, the epidemic continues in the United States and the international community. Globally, AIDS-related deaths have dropped by 45 percent since their peak in 2004. Yet the rate of HIV transmission remains unacceptably high, with 2.1 million new infections occurring worldwide in 2015 alone.   Source: NIH-NIAID

Back to Top

Regulations & Guidelines                     


HIV Vaccine Research



WHO-UNAIDS HIV Vaccine Initiative

Back to Top


Best Practices                  
Key Learnings as of August 2017
Historically, vaccination has been the best method for protecting people from infectious diseases. While an array of techniques are available for preventing HIV infection, the development of a safe and effective HIV vaccine remains key to realizing a durable end to the HIV/AIDS pandemic. NIAID-supported scientists are working toward an HIV vaccine from two complementary angles: an empirical approach that quickly moves vaccine candidates into human testing, and a theoretical approach that designs vaccine candidates based on an understanding of the immune response to HIV infection. Source: NIH-NIAID
Related Articles

 MedlinePlus - HIV Vaccine

Back to Top


Instructional Resources                  
Fact Sheets

History of HIV Vaccine Research

Back to Top


Patient Resources               

(1) Answers about HIV vaccine research

(2) Global HIV Vaccine Enterprise



OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.